ARK Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167M | Sell |
|
|||||
|
2025
Q1 | $184M | Buy |
|
|||||
|
2024
Q4 | $219M | Sell |
|
|||||
|
2024
Q3 | $216M | Buy |
|
|||||
|
2024
Q2 | $211M | Buy |
|
|||||
|
2024
Q1 | $245M | Buy |
|
|||||
|
2023
Q4 | $204M | Buy |
|
|||||
|
2023
Q3 | $52.6M | Buy |
|
|||||
|
2023
Q2 | $35.4M | Buy |
|
|||||
|
2023
Q1 | $23.9M | Buy |
|
|||||
|
2022
Q4 | $23.9M | Sell |
|
|||||
|
2022
Q3 | $35.7M | Buy |
|
|||||
|
2022
Q2 | $16.7M | Sell |
|
|||||
|
2022
Q1 | $20.2M | Buy |
|
|||||
|
2021
Q4 | $38.2M | Sell |
|
|||||
|
2021
Q3 | $59.7M | Buy |
|
|||||
|
2021
Q2 | $86.8M | Buy |
|